LOGAN RUMMELLS: Open Payments
NPI 1851098164 · NEWBERN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$740 in 48 payments from 6 companies in 2025. Trend: 2023 $181 · 2024 $589 · 2025 $740
Food & beverage: $740
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $327 |
| ABBVIE INC. | 14 | $179 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $134 |
| AstraZeneca Pharmaceuticals LP | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Lilly USA, LLC | 1 | $17 |
Products named: Ozempic, JARDIANCE, Wegovy, VRAYLAR, QULIPTA, BREZTRI, CAPLYTA, UBRELVY.
Industry payments across TN — which companies pay providers there.
